CoreySCutlerMD

Oncology • Boston, MA

Hematologic Oncology

Associate Professor, Medicine-Brigham & Women's Hospital, Harvard Medical School

Join to view full profile

Are you Dr. Cutler?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 76 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
44 Binney Streetd1b30
Danafarber Cancer Institute
Boston, MA 02115
Phone+1 617-632-5946

Fax+1 617-632-5168
Is this information wrong?

Summary

Dr. Corey Cutler, MD is an oncologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts, Vermont, and Florida. He is affiliated with Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Salem Hospital.

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1999 - 2002
McGill University Faculty of MedicineClass of 1996

Certifications & Licensure

FL State Medical License 2022 - Present
MA State Medical License 1999 - 2026
VT State Medical License 2023 - 2024
American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com

Clinical Trials

Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201) Start of enrollment: 2004 Jan 01
Completed
Phase 3
Rituximab Therapy for Steroid-Refractory Chronic Graft Versus Host Disease Start of enrollment: 2004 Jan 01
Completed
Phase 1, Phase 2
Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation Start of enrollment: 2003 Nov 01
Completed
Phase 2
Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation Start of enrollment: 2002 Jul 01
Completed
Phase 2
Rituximab for Prevention of Chronic GVHD Start of enrollment: 2006 Sep 01
Completed
Phase 1, Phase 2
Campath in Chronic GVHD Start of enrollment: 2007 Jul 01
Completed
Phase 1
Sirolimus, Mycophenolate Mofetil and Bortezomib as Graft-Versus-Host Disease (GVHD) Prophylaxis After Reduced Intensity Conditioning (RIC) Hematopoietic Stem Cell Transplantation Start of enrollment: 2007 Oct 01
Terminated
Phase 2
Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies. Start of enrollment: 2011 Jan 01
Completed
Phase 1
Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801) Start of enrollment: 2010 Apr 01
Completed
Phase 2, Phase 3
Alefacept in Subjects With Steroid-Refractory Chronic Graft-versus-Host Disease Start of enrollment: 2010 Oct 01
Terminated
Phase 2
Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease Start of enrollment: 2011 Mar 01
Completed
Phase 2
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
Recruiting
Reduced Intensity Double Umbilical Cord Blood Transplantation Start of enrollment: 2011 Dec 01
Completed
Phase 2
Brentuximab Vedotin for Steroid Refractory GvHD Start of enrollment: 2012 Jul 01
Completed
Phase 1
The PUMA Trial is a Trial of a Single ProHema Modulated-Cord Blood (CB) Unit as Part of a Double CB Transplant in Patients With Hematologic Malignancies. Start of enrollment: 2012 Jul 01
Terminated
Phase 2
Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the National Cord Blood Program (NCBP) for Unrelated Transplantation Start of enrollment: 2012 Feb 01
Recruiting
Phase 2
Allo vs Hypomethylating/Best Supportive Care in MDS (BMTCTN1102) Start of enrollment: 2013 Dec 16
Completed
Phase 2
Phase I Trial of LDE225 for Steroid-refractory Chronic GVHD After Allogeneic HSCT Start of enrollment: 2014 Apr 01
Terminated
Phase 1
An Open Label Phase II Trial of Topical Sirolimus for the Treatment of Refractory Oral Chronic Graft-versus-Host-Disease Start of enrollment: 2014 Jul 01
Terminated
Phase 2
Phase II Trial of Natalizumab + Prednisone for Initial Therapy of Acute GI GVHD Start of enrollment: 2015 Jan 01
Completed
Phase 2
Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study Start of enrollment: 2020 Jun 29
Recruiting
Join now to see all

Publications & Presentations

PubMed

Characterization of orofacial features in sclerodermatous chronic graft-versus-host disease.
Amal Bajonaid, Praveen Kumar Guntaka, Matthew Harper, Christine Duncan, Alessandro Villa, Hervé Y Sroussi, Sook-Bin Woo, Nathaniel S Treister, Corey Cutler> ;Oral Diseases. 2024 Mar 21
1 citations
Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML.
Garcia, J., Kim, H., Murdock, H., Ansuinelli, M., Brock, J., Cutler, C., Gooptu, M., Ho, V., Koreth, J., Nikiforow, S., Romee, R., Shapiro, R., DeAngelo, D., Stone, R....> ;Blood Advances. 2024 Feb 27
Cost-Effectiveness of Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Older Patients With High-Risk Myelodysplastic Syndrome: Analysis of BMT CTN 1...
Wael Saber, Aasthaa Bansal, Lily Li, Bart L Scott, Lindsey R Sangaralingham, Viengneesee Thao, Joshua A Roth, Winona Wright, Lotte M G Steuten, Joseph A Pidala, Asmita...> ;JCO Oncology Practice. 2024 Apr 1
1 citations
Second-Line Chimeric Antigen Receptor T-Cell Therapy in Diffuse Large B-Cell Lymphoma : A Cost-Effectiveness Analysis.
Amar H Kelkar, Edward R Scheffer Cliff, Caron A Jacobson, Gregory A Abel, Stijntje W Dijk, Eline M Krijkamp, Robert Redd, Joanna C Zurko, Mehdi Hamadani, M G Myriam Hu...> ;Annals of Internal Medicine. 2023 Dec 1
1 citations
Opportunistic Infections in Patients Receiving Post-Transplantation Cyclophosphamide: Impact of Haploidentical versus Unrelated Donor Allograft.
Jessica S Little, Rémy Duléry, Roman M Shapiro, Muneerah M Aleissa, Susan E Prockop, John Koreth, Jerome Ritz, Joseph H Antin, Corey Cutler, Sarah Nikiforow, Rizwan Ro...> ;Transplantation and Cellular Therapy. 2024 Feb 1
Digital Health to Patient-Facing Artificial Intelligence: Ethical Implications and Threats to Dignity for Patients With Cancer.
Amar H Kelkar, Andrew Hantel, Erica Koranteng, Corey S Cutler, Marilyn J Hammer, Gregory A Abel> ;JCO Oncology Practice. 2024 Mar 1
2 citations
Dental evaluation and clearance prior to allogeneic hematopoietic cell transplantation.
David Dean, Stephanie J Lee, Corey Cutler, Ted A Gooley, Philippe Hujoel, Uhlee Yuri Oh, Lisa Bennett-Johnson, Mary K Hagstrom, Marilynn Rothen, Michele Lloid, Herve S...> ;Oral Diseases. 2023 Aug 31
Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow...
Jurjen Versluis, Wael Saber, Harrison K Tsai, Christopher J Gibson, Laura W Dillon, Asmita Mishra, Joseph McGuirk, Richard T Maziarz, Peter Westervelt, Pranay Hegde, D...> ;Journal of Clinical Oncology. 2023 Oct 1
5 citations
Posttransplant cyclophosphamide vs tacrolimus-based GVHD prophylaxis: lower incidence of relapse and chronic GVHD.
Katie Maurer, Vincent T Ho, Eno Inyang, Corey Cutler, John Koreth, Roman M Shapiro, Mahasweta Gooptu, Rizwan Romee, Sarah Nikiforow, Joseph H Antin, Catherine J Wu, Je...> ;Blood Advances. 2023 Aug 8
Medication Adherence in Patients with Hematologic Malignancies Who Are Hematopoietic Stem Cell Transplantation Survivors: A Qualitative Study.
Hermioni L Amonoo, Emma C Deary, Annie Wang, Richard A Newcomb, Elizabeth Daskalakis, Daniel Weber, Katherine E Holmbeck, Joanna J Choe, Anisa Nabily, Corey Cutler, La...> ;Transplantation and Cellular Therapy. 2023 Oct 1
1 citations
Positive Psychological Well-Being in Hematopoietic Stem Cell Transplantation Survivors.
Hermioni L Amonoo, Jeffrey A Lam, Elizabeth Daskalakis, Emma C Deary, Christopher Celano, Henry K Onyeaka, Anna Barata, Nora Horick, Corey Cutler, William F Pirl, Step...> ;Transplantation and Cellular Therapy. 2023 Sep 1
2 citations
Feasibility of a positive psychology intervention (PATH) in allogeneic hematopoietic stem cell transplantation survivors: Randomized pilot trial design and methods.
Hermioni L Amonoo, Elizabeth Daskalakis, Emma C Deary, Christopher M Celano, Pia Maria Ghanime, Brian C Healy, Corey Cutler, William F Pirl, Elyse R Park, Lisa M Guden...> ;Contemporary Clinical Trials. 2023 Aug 1
3 citations
Patient-reported treatment response in chronic graft--host disease.
Annie Im, Iskra Pusic, Lynn Onstad, Carrie L Kitko, Betty K Hamilton, Amin M Alousi, Mary E Flowers, Stefanie Sarantopoulos, Paul Carpenter, Jennifer White, Sally Arai...> ;Haematologica. 2024 Jan 1
Cytokine release syndrome in haploidentical stem cell transplant may impact T-cell recovery and relapse.
Roman M Shapiro, Haesook T Kim, Michela Ansuinelli, Indira Guleria, Corey S Cutler, John Koreth, Mahasweta Gooptu, Joseph H Antin, Amar Kelkar, Jerome Ritz, Catherine ...> ;Blood Advances. 2023 Aug 8
2 citations
A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis.
Roni Tamari, Donal P McLornan, Kwang Woo Ahn, Noel Estrada-Merly, Juan Carlos Hernández-Boluda, Sergio Giralt, Jeanne Palmer, Robert Peter Gale, Zachariah DeFilipp, Da...> ;Blood Advances. 2023 Aug 8
1 citations
Whole-genome sequencing identifies novel predictors for hematopoietic cell transplant outcomes for patients with myelodysplastic syndrome: a CIBMTR study.
Tao Zhang, Paul Auer, Jing Dong, Corey Cutler, Amy E Dezern, Shahinaz M Gadalla, H Joachim Deeg, Aziz Nazha, Karen-Sue Carlson, Stephen Spellman, Yung-Tsi Bolon, Wael ...> ;Journal of Hematology & Oncology. 2023 Apr 11
Clinical Features of Acute Kidney Injury in the Early Post-Transplantation Period Following Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplan...
Juliana Vergara-Cadavid, P Connor Johnson, Haesook T Kim, Alisha Yi, Meghan E Sise, David E Leaf, Paul E Hanna, Vincent T Ho, Corey S Cutler, Joseph H Antin, Mahasweta...> ;Transplantation and Cellular Therapy. 2023 Jul 1
Prognostic landscape of mitochondrial genome in myelodysplastic syndrome after stem-cell transplantation.
Jing Dong, Christopher Staffi Buradagunta, Tao Zhang, Stephen Spellman, Yung-Tsi Bolon, Amy E DeZern, Shahinaz M Gadalla, H Joachim Deeg, Aziz Nazha, Corey Cutler, Cha...> ;Journal of Hematology & Oncology. 2023 Mar 10
2 citations
Phase 2 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease.
Anita G Koshy, Haesook T Kim, Jessica Liegel, Jon Arnason, Vincent T Ho, Joseph H Antin, Robin Joyce, Corey Cutler, Mahasweta Gooptu, Sarah Nikiforow, Emma K Logan, Pa...> ;Blood. 2023 Jun 15
The development of graft--host disease prophylaxis.
Corey Cutler> ;Haematologica. 2023 Mar 1
2 citations
Delirium and Healthcare Utilization in Patients Undergoing Hematopoietic Stem Cell Transplantation.
Hermioni L Amonoo, Netana H Markovitz, P Connor Johnson, Anne Kwok, Ciara Dale, Emma C Deary, Elizabeth Daskalakis, Joanna J Choe, Nikka Yamin, Maanasi Gothoskar, Kath...> ;Transplantation and Cellular Therapy. 2023 May 1
3 citations
Lower incidence of chronic GVHD observed after transplantation with cryopreserved unrelated allogeneic stem cells.
Katie Maurer, Haesook T Kim, Heather M Garrity, Deborah Liney, Corey Cutler, Joseph H Antin, John Koreth, Jerome Ritz, Roman M Shapiro, Rizwan Romee, Vincent T Ho, Mah...> ;Blood Advances. 2023 Jun 13
5 citations
Health-Related Quality of Life Following Allogeneic Hematopoietic Cell Transplantation with Omidubicel versus Umbilical Cord Blood.
Rezvani, A. R., Chenyu Lin, Gautam Sajeev, Patrick J Stiff, Claudio G Brunstein, Corey Cutler, Guillermo Sanz, Caroline A Lindemans, Andrew R Rezvani, Rabi Hanna, Lian...> ;Transplantation and Cellular Therapy. 2023 Jan 1
4 citations
Hematopoietic Cell Transplantation in the Management of Myelodysplastic Syndrome: An Evidence-Based Review from the American Society for Transplantation and Cellular T...
Zachariah DeFilipp, Stefan O Ciurea, Corey Cutler, Marie Robin, Erica D Warlick, Ryotaro Nakamura, Andrew M Brunner, Bhagirathbhai Dholaria, Alison R Walker, Nicolaus ...> ;Transplantation and Cellular Therapy. 2023 Feb 1
18 citations
Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings.
Jacqueline S Garcia, Yael Flamand, Livius Penter, Michael Keng, Benjamin K Tomlinson, Lourdes M Mendez, Paul Koller, Nicole Cullen, Yohei Arihara, Kathleen Pfaff, Jacq...> ;Blood. 2023 Apr 13
Join now to see all

Press Mentions

Notice of Compliance Issued Regarding Rezurock(TM) (Belumosudil Tablets)March 21st, 2023
GVHD Alliance to Honor Steven Pavletic with the Inaugural Lukas D. Wartman GVHD Achievement AwardFebruary 16th, 2023
FDA Action Alert: Cara/Vifor, Kadmon, BMS, Merck/EisaiAugust 23rd, 2021
Join now to see all

Hospital Affiliations

Brigham and Women's HospitalBoston, Massachusetts
Dana-Farber Cancer InstituteBoston, Massachusetts
Salem HospitalSalem, Massachusetts